GLP-1 Peptide HPLC Purity: How to Verify a CoA Is Authentic

When an institutional buyer receives a certificate of analysis (CoA) for a GLP-1 research peptide, the document is only as trustworthy as the analytical data behind it. Most supplier pages describe what a CoA should contain. Far fewer explain how to read the underlying chromatogram and mass spectrum to determine whether the reported GLP-1 peptide HPLC purity figure is genuine — or a number typed into a template. This guide covers the specific, checkable details that separate an authentic CoA from a fabricated one, drawn from supplier audits and analytical review workflows used at Helix Peptide.

Why GLP-1 Peptide HPLC Purity Is the Hardest Number to Fake Well

HPLC purity is expressed as the area percentage of the principal peak relative to total integrated peak area at a specified wavelength (typically 214 nm for peptides, sometimes 220 nm). For a GLP-1 analog such as tirzepatide or retatrutide, a genuine 98%+ purity figure implies a chromatogram with a clean main peak and only minor, well-resolved impurity peaks. Fabricating that number is easy. Fabricating a chromatogram that looks like it came from a real run is much harder, because experienced reviewers check the following:

• Retention time consistency with the stated column, gradient, and flow rate.
• Peak symmetry (asymmetry factor) — real peptide peaks are rarely perfectly symmetrical.
• Baseline noise — a flat, zero-noise baseline suggests a redrawn or synthetic trace.
• Impurity profile logic — deletion sequences, oxidation products, and diastereomers appear at predictable relative positions.
• Y-axis scaling — a main peak that touches the top of the chart with no visible minor peaks is a common sign of a cropped or edited image.

If any of these are absent or implausible, the reported purity percentage should be treated as unverified until independent testing is performed.

Reading the Chromatogram: A Reviewer's Checklist

Ask the supplier for the raw chromatogram file (e.g., .cdf, .raw, or .wiff), not just a screenshot embedded in a PDF. A screenshot can be edited; a raw file can be re-integrated by your own lab. When only a PDF is available, apply this checklist:

1. Method parameters must be stated

• Column make, model, dimensions, and particle size (e.g., C18, 4.6 × 250 mm, 5 µm).
• Mobile phase composition and gradient program with time points.
• Flow rate, column temperature, injection volume, and detection wavelength.
• Run time and approximate retention time of the main peak.

A CoA that reports "purity: 99.1%" without these parameters is not a usable analytical record for institutional review.

2. The impurity profile must be chemically plausible

For a GLP-1 analog, expect to see minor peaks consistent with:

• Deletion or truncation sequences (often eluting close to the main peak).
• Oxidation products (e.g., methionine sulfoxide), typically eluting slightly earlier or later depending on gradient.
• Diastereomers from racemization during synthesis.
• Residual protecting group adducts in poorly purified lots.

A chromatogram showing a single perfect peak with no minor peaks at all is a red flag — even high-purity research peptides show trace impurities at 214 nm.

3. Mass spectrometry must corroborate the HPLC result

HPLC purity alone does not confirm identity. A genuine CoA pairs the chromatogram with a mass spectrum (ESI-MS or MALDI-TOF) showing the expected monoisotopic or average mass within a stated tolerance (typically ±0.5 Da for small peptides, wider for larger analogs). Check that the observed mass matches the theoretical mass of the stated sequence, and that the isotope envelope looks like a real peptide, not a synthetic pattern.

Cross-Checking the CoA Against the Lot

An authentic CoA is lot-specific. The lot number on the CoA must match the lot number on the vial label, the shipping documentation, and any accompanying SDS. Common failure modes observed in supplier audits include:

• Reused CoA numbers across multiple lots — a sign of a template document.
• Missing or inconsistent test dates relative to the manufacturing date.
• Analyst or QA signatures that are typed rather than signed, or that belong to a person not listed on the supplier's quality organization chart.
• Instrument IDs that cannot be traced to a calibration record.

For a deeper walkthrough of how to read a tirzepatide-specific CoA, including sequence and counter-ion details, see our tirzepatide CoA guide. For general CoA interpretation across peptide classes, the Helix CoA guide covers the document structure, required fields, and retention-time expectations.

Real Failure Cases from Supplier Audits

The following patterns are drawn from anonymized audit findings and are representative of what institutional buyers encounter:

Case 1: The "99.5%" CoA with a cropped chromatogram

A buyer requested the raw chromatogram for a GLP-1 analog lot. The PDF showed a single sharp peak labeled 99.5%. The raw file, when re-integrated by the buyer's lab, revealed a shoulder on the main peak and three minor peaks that had been manually excluded from integration. Re-integrated purity: 94.2%. The supplier had not fabricated the data, but had applied non-standard integration parameters that inflated the reported figure.

Case 2: Mass spectrum from a different peptide

In a second audit, the CoA's mass spectrum showed an observed mass inconsistent with the stated sequence by approximately 14 Da — consistent with an extra methylene group. The supplier had reused a mass spectrum from a related but distinct analog. HPLC purity was genuine; identity was not.

Case 3: The template CoA

A supplier provided CoAs for three different lots with identical chromatogram images, identical retention times, and identical impurity profiles. The only difference was the lot number. This is a clear indicator of a template document rather than lot-specific testing.

What to Request from Any Supplier

To verify GLP-1 peptide HPLC purity and overall CoA authenticity, request the following before placing a research order:

• Raw chromatogram and mass spectrum files, not just PDF screenshots.
• Full method parameters (column, gradient, flow rate, detection wavelength).
• Lot-specific CoA with matching lot number on vial and shipping documents.
• Statement of whether purity is area-percent at 214 nm or another wavelength.
• Independent third-party test results, if available, from a recognized analytical laboratory.
• QA contact who can answer method and integration questions directly.

If a supplier cannot provide raw data or method parameters, the CoA should be treated as a marketing document rather than an analytical record.

Conclusion: GLP-1 Peptide HPLC Purity Verification Is a Data-Review Exercise

Verifying that a CoA is authentic is not about trusting a percentage. It is about reviewing the chromatogram, the mass spectrum, the method parameters, and the lot traceability as a connected dataset. For institutional buyers, the practical takeaway is to request raw files, apply the checklist above, and cross-check identity via mass spectrometry before accepting any purity claim. For research procurement teams that need documented, lot-specific analytical support, contact our QA team to request a quote and discuss the analytical documentation available for your GLP-1 research peptide requirements.